Medical Action Industries Announces Fourth Quarter and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Medical Action Industries Announces Fourth Quarter and Year-End Earnings Call to Take Place on June 11, 2014

BRENTWOOD, N.Y., June 4, 2014 (GLOBE NEWSWIRE) -- Medical Action Industries Inc. (Nasdaq: MDCI ), announced today that it will hold a conference call on Wednesday, June 11, 2014 at 10:00 a.m. (ET) to present its financial results for the quarter and year ended March 31, 2014.

The conference call will be conducted by Mr. Paul D. Meringolo, Chief Executive Officer, Mr. Paul Chapman, President and Chief Operating Officer and Mr. Brian Baker, Chief Financial Officer. Medical Action announced that the results of operations for the quarter and year ended March 31, 2014 will be released on Wednesday, June 11, 2014 before the market opens.

The conference call will be simultaneously webcast on our website: www.medical-action.com . The dial-in number for the conference call is (888) 868-9080 ( domestic ) or (973) 935-8511 ( international ) ; conference I D# 56537571 . The complete call and discussion will be available for replay on our website beginning at 1:00 p.m. (ET) on June 11, 2014.

Medical Action is a diversified manufacturer and distributor of disposable medical devices and a leader in many of the markets where it competes. Its products are marketed primarily to acute care facilities in domestic and certain international markets. The Company has expanded its target market to include physician, dental and veterinary office, out-patient surgery centers, long-term care facilities and laboratories. Medical Action's products are marketed nationally by its direct sales personnel and extensive network of healthcare distributors. The Company has preferred vendor agreements with national and regional distributors, as well as sole and multi-source agreements with group purchasing organizations. Medical Action's common stock trades on the NASDAQ Global Select Market under the symbol MDCI and is included in the Russell 2000 ® Index.

Brian Baker - Chief Financial Officer MEDICAL ACTION INDUSTRIES INC. (631) 231-4600

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Current Market Sentiment on HealthEquity Shares: A Closer Look

Updated Category News Views 113

Understanding HealthEquity's Short Interest Dynamics HealthEquity Inc (NYSE: HQY) has seen a significant decrease in its short percent of float, which recently dropped by 11.68%. As of the last report, the company had approximately 5.26 million shares sold short, representing 7.03% of its regular shares available for trading. This situation also highlights an average...

Continue Reading
Investors Update: Class Action Against Bumble Inc. Soon

Updated Category News Views 104

Update on Class Action Lawsuit Against Bumble Inc. (BMBL) The Law Offices of Frank R. Cruz are reminding investors about an upcoming significant deadline concerning a class action lawsuit against Bumble Inc. This lawsuit affects investors who acquired BMBL securities during the designated Class Period. Understanding the Class Action Lawsuit The class action was initiated...

Continue Reading
Analysis of Williams-Sonoma's Recent Surge and Current Changes

Updated Category News Views 293

Understanding Williams-Sonoma's Recent Stock Movements This week has seen an impressive rise of nearly 30% in shares of Williams-Sonoma, Inc. (NYSE: WSM), but recent trading indicates a slight pullback. Investors are reacting to two key factors: the natural tendency to take profits and the decision of some buyers to exit losing positions as market conditions evolve. The...

Continue Reading
Understanding the Arconic Corporation Class Action Update

Updated Category News Views 139

Overview of the Class Action Lawsuit Against Arconic Corporation Levi & Korsinsky, LLP has recently announced a class action regarding Arconic Corporation (ARNC). This situation affects investors who may have been impacted by alleged securities fraud. The firm aims to represent those who traded Arconic shares during a specified period and seeks to recover losses resulting...

Continue Reading
Cambrex Partners with Lilly to Enhance Biotech Innovations

Updated Category News Views 220

Cambrex's Strategic Collaboration with Eli Lilly Cambrex, a key player in the global contract development and manufacturing organization (CDMO) sector, has announced an exciting new partnership with Eli Lilly and Company to enhance support for biotech collaborators. Through this agreement, Cambrex aims to provide accelerated access to essential clinical development...

Continue Reading